Absorb IV Randomized Controlled Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2604 participants.
Also called NCT02173379
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,604 participants
- Sponsor
- Registry
-
NCT02173379
-
- Other papers using this trial's data
- 5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Canada, Germany, Singapore
- Registry status
- Completed
Technical summary
Registry record NCT02173379. Randomized; single masking; primary purpose treatment. Start 2014-07 (actual); primary completion 2022-04-06 (actual). Results posted on 2018-07-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Absorb IV Randomized Controlled Trial
- Condition
- Coronary Artery Disease
- Condition
- Coronary Artery Stenosis
- Condition
- Coronary Disease
- Condition
- Coronary Stenosis
- Intervention (Device)
- Absorb BVS
- Intervention (Device)
- XIENCE
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct02173379- Content hash
8f678eff98d00474abb2fb0b00a9a6b7af4afc1cdf2c7a8f7204ced2bdbf4f82